- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 3 residues within 4Å:- Chain A: N.46, S.48, Q.49
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.46, A:S.48, A:Q.49
NAG.12: 3 residues within 4Å:- Chain B: N.46, S.48, Q.49
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.46, B:S.48, B:Q.49
NAG.16: 3 residues within 4Å:- Chain C: N.46, S.48, Q.49
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.46, C:S.48, C:Q.49
NAG.20: 3 residues within 4Å:- Chain D: N.46, S.48, Q.49
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:N.46, D:S.48, D:Q.49
NAG.24: 3 residues within 4Å:- Chain E: N.46, S.48, Q.49
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:N.46, E:S.48, E:Q.49
- 5 x CLR: CHOLESTEROL(Non-covalent)
CLR.7: 8 residues within 4Å:- Chain A: I.313, Y.317, W.330, T.331, I.334, L.470, C.471, A.474
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.313, A:W.330, A:I.334, A:A.474
CLR.13: 8 residues within 4Å:- Chain B: I.313, Y.317, W.330, T.331, I.334, L.470, C.471, A.474
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:I.313, B:W.330, B:I.334, B:A.474
CLR.17: 8 residues within 4Å:- Chain C: I.313, Y.317, W.330, T.331, I.334, L.470, C.471, A.474
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:I.313, C:W.330, C:I.334, C:A.474
CLR.21: 8 residues within 4Å:- Chain D: I.313, Y.317, W.330, T.331, I.334, L.470, C.471, A.474
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:I.313, D:W.330, D:I.334, D:A.474
CLR.25: 8 residues within 4Å:- Chain E: I.313, Y.317, W.330, T.331, I.334, L.470, C.471, A.474
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:I.313, E:W.330, E:I.334, E:A.474
- 5 x I33: 7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide(Non-covalent)
I33.8: 14 residues within 4Å:- Chain A: S.56, L.57, S.58, W.77, L.78, Q.79, L.141, D.186
- Chain E: Y.115, W.171, Y.210, E.211, C.212, Y.217
11 PLIP interactions:6 interactions with chain A, 5 interactions with chain E- Hydrophobic interactions: A:W.77, A:W.77, A:W.77, A:W.77, A:Q.79, A:L.141, E:W.171, E:Y.210, E:Y.210
- Hydrogen bonds: E:E.211, E:C.212
I33.10: 14 residues within 4Å:- Chain A: Y.115, W.171, Y.210, E.211, C.212, Y.217
- Chain B: S.56, L.57, S.58, W.77, L.78, Q.79, L.141, D.186
11 PLIP interactions:6 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: B:W.77, B:W.77, B:W.77, B:W.77, B:Q.79, B:L.141, A:W.171, A:Y.210, A:Y.210
- Hydrogen bonds: A:E.211, A:C.212
I33.14: 14 residues within 4Å:- Chain B: Y.115, W.171, Y.210, E.211, C.212, Y.217
- Chain C: S.56, L.57, S.58, W.77, L.78, Q.79, L.141, D.186
11 PLIP interactions:5 interactions with chain B, 6 interactions with chain C- Hydrophobic interactions: B:W.171, B:Y.210, B:Y.210, C:W.77, C:W.77, C:W.77, C:W.77, C:Q.79, C:L.141
- Hydrogen bonds: B:E.211, B:C.212
I33.18: 14 residues within 4Å:- Chain C: Y.115, W.171, Y.210, E.211, C.212, Y.217
- Chain D: S.56, L.57, S.58, W.77, L.78, Q.79, L.141, D.186
11 PLIP interactions:6 interactions with chain D, 5 interactions with chain C- Hydrophobic interactions: D:W.77, D:W.77, D:W.77, D:W.77, D:Q.79, D:L.141, C:W.171, C:Y.210, C:Y.210
- Hydrogen bonds: C:E.211, C:C.212
I33.22: 14 residues within 4Å:- Chain D: Y.115, W.171, Y.210, E.211, C.212, Y.217
- Chain E: S.56, L.57, S.58, W.77, L.78, Q.79, L.141, D.186
11 PLIP interactions:5 interactions with chain D, 6 interactions with chain E- Hydrophobic interactions: D:W.171, D:Y.210, D:Y.210, E:W.77, E:W.77, E:W.77, E:W.77, E:Q.79, E:L.141
- Hydrogen bonds: D:E.211, D:C.212
- 5 x I34: N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea(Non-covalent)
I34.9: 13 residues within 4Å:- Chain A: L.235, N.236, P.240, I.244, F.275, L.278
- Chain E: T.273, M.276, L.277, V.290, A.294, A.298, M.301
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain E- Hydrophobic interactions: A:L.235, A:L.235, A:P.240, A:F.275, E:V.290, E:A.298
I34.11: 13 residues within 4Å:- Chain A: T.273, M.276, L.277, V.290, A.294, A.298, M.301
- Chain B: L.235, N.236, P.240, I.244, F.275, L.278
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:L.235, B:L.235, B:P.240, B:F.275, A:V.290, A:A.298
I34.15: 13 residues within 4Å:- Chain B: T.273, M.276, L.277, V.290, A.294, A.298, M.301
- Chain C: L.235, N.236, P.240, I.244, F.275, L.278
6 PLIP interactions:4 interactions with chain C, 2 interactions with chain B- Hydrophobic interactions: C:L.235, C:L.235, C:P.240, C:F.275, B:V.290, B:A.298
I34.19: 13 residues within 4Å:- Chain C: T.273, M.276, L.277, V.290, A.294, A.298, M.301
- Chain D: L.235, N.236, P.240, I.244, F.275, L.278
6 PLIP interactions:4 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:L.235, D:L.235, D:P.240, D:F.275, C:V.290, C:A.298
I34.23: 13 residues within 4Å:- Chain D: T.273, M.276, L.277, V.290, A.294, A.298, M.301
- Chain E: L.235, N.236, P.240, I.244, F.275, L.278
6 PLIP interactions:2 interactions with chain D, 4 interactions with chain E- Hydrophobic interactions: D:V.290, D:A.298, E:L.235, E:L.235, E:P.240, E:F.275
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, Y. et al., Structural basis of human alpha 7 nicotinic acetylcholine receptor activation. Cell Res. (2021)
- Release Date
- 2021-05-19
- Peptides
- Neuronal acetylcholine receptor subunit alpha-7: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x CLR: CHOLESTEROL(Non-covalent)
- 5 x I33: 7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide(Non-covalent)
- 5 x I34: N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, Y. et al., Structural basis of human alpha 7 nicotinic acetylcholine receptor activation. Cell Res. (2021)
- Release Date
- 2021-05-19
- Peptides
- Neuronal acetylcholine receptor subunit alpha-7: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.